SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2023-08-18 11:26
Tx date 2023-08-15 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$82,800
+30,000 vol
$2.76 each 		95,263
Filed 2022-06-21 15:40
Tx date 2022-06-20 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$34,200
+30,000 vol
$1.14 each 		65,263
Filed 2022-01-04 14:24
Tx date 2022-01-04 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+3,142 vol 		121,925
Filed 2022-01-04 14:22
Tx date 2022-01-04 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
-3,142 vol 		0
Filed 2021-10-04 18:09
Tx date 2021-10-01 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+8,134 vol 		118,783
Filed 2021-10-04 18:08
Tx date 2021-10-01 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
-8,134 vol 		3,142
Filed 2021-10-04 18:07
Tx date 2021-09-30 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+2,313 vol 		110,649
Filed 2021-10-04 18:04
Tx date 2021-09-30 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
-2,313 vol 		11,276
Filed 2021-06-30 16:00
Tx date 2021-06-30 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
-2,313 vol 		13,589
Filed 2021-06-30 11:25
Tx date 2021-06-30 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Holder: Paul Holtham (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$7,933
+2,313 vol
$3.43 each 		5,313
Filed 2021-06-07 12:48
Tx date 2021-06-07 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$25,123
+7,000 vol
$3.59 each 		108,336
Filed 2021-04-01 10:24
Tx date 2021-03-31 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+1,167 vol 		101,336
Filed 2021-04-01 10:22
Tx date 2021-03-31 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
-1,167 vol 		15,902
Filed 2021-03-12 18:19
Tx date 2021-03-08 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$102,000
+30,000 vol
$3.40 each 		35,263
Filed 2021-01-04 15:37
Tx date 2020-12-31 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+1,053 vol 		100,169
Filed 2021-01-04 15:36
Tx date 2020-12-31 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
-1,053 vol 		17,069
Filed 2020-12-02 15:52
Tx date 2020-12-01 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+3,971 vol 		99,116
Filed 2020-12-02 15:50
Tx date 2020-12-01 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
-3,971 vol 		18,122
Filed 2020-10-05 19:22
Tx date 2020-10-05 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+17,483 vol 		95,145
Filed 2020-10-05 19:21
Tx date 2020-10-05 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
-17,483 vol 		22,093
Filed 2020-10-05 19:20
Tx date 2020-10-01 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights
+17,483 vol 		39,576
Filed 2020-10-02 10:03
Tx date 2020-09-30 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+1,144 vol 		77,662
Filed 2020-10-02 10:02
Tx date 2020-09-30 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
-1,144 vol 		22,093
Filed 2020-08-28 10:04
Tx date 2020-08-28 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$10,105
+4,300 vol
$2.35 each 		76,518
Filed 2020-07-03 09:58
Tx date 2020-06-30 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+1,496 vol 		72,218
Filed 2020-07-03 09:56
Tx date 2020-06-30 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
-1,496 vol 		23,237
Filed 2020-04-06 16:39
Tx date 2020-04-06 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+1,165 vol 		70,722
Filed 2020-04-06 16:34
Tx date 2020-04-06 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
-1,165 vol 		24,733
Filed 2020-03-30 10:35
Tx date 2020-03-27 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Holder: Paul Holtham (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$6,089
+3,000 vol
$2.03 each 		3,000
Filed 2020-03-30 10:03
Tx date 2020-03-27 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Holder: Paul Holtham (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$6,000
+3,000 vol
$2.00 each
Filed 2020-03-30 10:02
Tx date 2014-06-18 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Holder: Paul Holtham (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-03-30 09:48
Tx date 2020-03-27 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$6,000
+3,000 vol
$2.00 each 		69,557
Filed 2020-01-17 10:59
Tx date 2020-01-16 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+3,968 vol 		66,557
Filed 2020-01-17 10:43
Tx date 2020-01-16 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+10,526 vol
Filed 2020-01-17 10:38
Tx date 2020-01-16 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
-10,526 vol 		25,898
Filed 2019-10-04 10:35
Tx date 2019-10-03 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+8,377 vol 		62,589
Filed 2019-10-04 10:34
Tx date 2019-10-01 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+44,827 vol 		54,212
Filed 2019-10-04 10:32
Tx date 2019-10-03 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
-8,377 vol 		36,424
Filed 2019-10-04 10:31
Tx date 2019-10-01 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
-44,827 vol 		44,801
Filed 2019-10-04 10:30
Tx date 2019-10-01 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights
+44,827 vol 		89,628
Filed 2019-04-02 14:31
Tx date 2019-03-31 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+965 vol 		9,385
Filed 2019-04-02 10:51
Tx date 2019-03-31 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+2,575 vol
Filed 2019-04-02 10:51
Tx date 2019-03-31 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+2,575 vol 		10,995
Filed 2019-04-02 10:50
Tx date 2019-03-31 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
-2,575 vol 		44,801
Filed 2019-04-02 10:49
Tx date 2019-03-31 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights
+2,575 vol 		47,376
Filed 2019-03-04
Tx date 2019-03-01 		$JWEL
Jamieson Wellness Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,964
+100 vol
$19.65 each 		1,000
Filed 2019-03-04
Tx date 2019-03-01 		$JWEL
Jamieson Wellness Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,971
+100 vol
$19.71 each 		1,300
Filed 2019-03-04
Tx date 2019-03-01 		$JWEL
Jamieson Wellness Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,940
+200 vol
$19.70 each 		1,200
Filed 2019-03-04
Tx date 2019-03-01 		$JWEL
Jamieson Wellness Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$7,840
+400 vol
$19.60 each 		900
Filed 2019-03-04
Tx date 2019-03-01 		$JWEL
Jamieson Wellness Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+9,301 vol 		27,254
Filed 2019-01-02
Tx date 2018-12-31 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights
+3,142 vol 		44,801
Filed 2018-11-30
Tx date 2018-05-22 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
37 - Stock split or consolidation
-290,427 vol 		34,162
Filed 2018-11-30
Tx date 2018-11-28 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+5,263 vol 		8,420
Filed 2018-11-30
Tx date 2018-11-27 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights
+12,760 vol 		46,922
Filed 2018-11-30
Tx date 2018-05-22 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-44,737 vol 		5,263
Filed 2018-11-30
Tx date 2018-11-28 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
-5,263 vol 		41,659
Filed 2018-11-30
Tx date 2018-05-22 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
-26,843 vol 		3,157
Filed 2018-11-13
Tx date 2018-11-12 		$JWEL
Jamieson Wellness Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$9,715
+500 vol
$19.43 each 		500
Filed 2018-11-13
Tx date 2017-09-01 		$JWEL
Jamieson Wellness Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-04
Tx date 2018-03-31 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights
+11,091 vol 		324,589
Filed 2018-01-03
Tx date 2018-01-01 		$JWEL
Jamieson Wellness Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+7,390 vol 		17,953
Filed 2018-01-02
Tx date 2017-12-31 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights
+10,011 vol 		313,498
Filed 2017-12-04
Tx date 2017-12-01 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights
+37,729 vol 		303,487
Filed 2017-11-10
Tx date 2017-10-31 		$JWEL
Jamieson Wellness Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+2,664 vol 		10,563
Filed 2017-10-07
Tx date 2017-09-01 		$JWEL
Jamieson Wellness Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-10-07
Tx date 2017-09-29 		$JWEL
Jamieson Wellness Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+7,899 vol 		7,899
Filed 2017-10-04
Tx date 2017-09-30 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights
+10,877 vol 		265,758
Filed 2017-07-05
Tx date 2017-06-30 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights
+14,219 vol 		254,881
Filed 2017-05-16
Tx date 2017-05-11 		$IBG
IBI Group Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Deferred Unit
59 - Exercise for cash
-10,000 vol 		0
Filed 2017-04-11
Tx date 2017-04-06 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights
+11,076 vol 		240,662
Filed 2017-04-04
Tx date 2017-03-31 		$IBG
IBI Group Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Deferred Unit
56 - Grant of rights 		$13,200
+2,000 vol
$6.60 each 		10,000
Filed 2017-01-19
Tx date 2017-01-16 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights
+100,000 vol 		229,586
Filed 2017-01-04
Tx date 2016-12-31 		$IBG
IBI Group Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Deferred Unit
56 - Grant of rights 		$11,720
+2,000 vol
$5.86 each 		8,000
Filed 2016-10-06
Tx date 2016-10-03 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights
+79,586 vol 		129,586
Filed 2016-10-04
Tx date 2016-09-30 		$IBG
IBI Group Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Deferred Unit
56 - Grant of rights 		$12,160
+2,000 vol
$6.08 each 		6,000
Filed 2016-07-05
Tx date 2016-06-30 		$IBG
IBI Group Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Deferred Unit
56 - Grant of rights 		$10,180
+2,000 vol
$5.09 each 		4,000
Filed 2016-04-04
Tx date 2016-03-31 		$IBG
IBI Group Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Deferred Unit
56 - Grant of rights
+2,000 vol 		2,000
Filed 2016-04-04
Tx date 2015-03-18 		$IBG
IBI Group Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Deferred Unit
00 - Opening Balance-Initial SEDI Report
Filed 2015-12-21
Tx date 2015-03-18 		$IBG
IBI Group Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2015-12-21
Tx date 2015-12-18 		$IBG
IBI Group Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Holder: Paul Holtham (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$10,080
+4,800 vol
$2.10 each 		4,800
Filed 2015-12-21
Tx date 2015-03-18 		$IBG
IBI Group Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Holder: Paul Holtham (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2015-12-14
Tx date 2015-12-09 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights 		$20,000
+50,000 vol
$0.40 each 		50,000
Filed 2015-12-14
Tx date 2014-06-18 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2015-05-27
Tx date 2015-05-26 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$13,350
+15,000 vol
$0.89 each 		30,000
Filed 2015-05-26
Tx date 2015-05-26 		$ONC
Oncolytics Biotech Inc. 		Holtham, Angela Frances
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$4,450
+5,000 vol
$0.89 each 		15,000